mTor: An Important Pathway in Targeting Cancer


Wyeth
May, 2007
In the ever-evolving field of cancer research, the understanding of potential new anti-cancer compounds is critical. In order for physicians to quickly learn and understand the mechanism of action of a key kinase, rapamycin (known as mTOR) which has become a focal point in anti-cancer pathway research, we utilized 3D animation to educate physicians about this highly complex, promising new pathway.
Agency Partner:
Saatchi & Saatchi Healthcare Innovations
Awards:
3 Tellys, 1 Rx Club, Global Award Finalist
